UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomized, Double-Blind, Placebo-Controlled Phase II Study of AMG 386 Combined With Weekly Paclitaxel in Patients With Recurrent Ovarian Cancer

Journal of clinical oncology, 2012-02, Vol.30 (4), p.362-371

2012

Volltextzugriff (PDF)

An Expanded Treatment Protocol of Panobinostat Plus Bortezomib and Dexamethasone in Patients With Previously Treated Myeloma

Clinical lymphoma, myeloma and leukemia, 2018-06, Vol.18 (6), p.400-407.e1

2018

Volltextzugriff (PDF)

Fixed combination of oral NEPA (netupitant‐palonosetron) for the prevention of acute and delayed chemotherapy‐induced nausea and vomiting in patients receiving multiple cycles of chemotherapy: Efficacy data from 2 randomized, double‐blind phase III studies

Cancer medicine (Malden, MA), 2019-05, Vol.8 (5), p.2064-2073

2019

Volltextzugriff (PDF)

Phase 2 trial results with the novel neurokinin‐1 receptor antagonist casopitant in combination with ondansetron and dexamethasone for the prevention of chemotherapy‐induced nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy

Cancer, 2009-12, Vol.115 (24), p.5807-5816

2009

Volltextzugriff (PDF)

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

The lancet oncology, 2020-04, Vol.21 (4), p.519-530

2020

Volltextzugriff (PDF)

Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma

The New England journal of medicine, 2019-05, Vol.380 (22), p.2104-2115

2019

Volltextzugriff (PDF)

Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

The lancet oncology, 2017-10, Vol.18 (10), p.1360-1372

2017

Volltextzugriff (PDF)

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

The lancet oncology, 2019-06, Vol.20 (6), p.862-876

2019

Volltextzugriff (PDF)

NEPA, a fixed oral combination of netupitant and palonosetron, improves control of chemotherapy-induced nausea and vomiting (CINV) over multiple cycles of chemotherapy: results of a randomized, double-blind, phase 3 trial versus oral palonosetron

Supportive care in cancer, 2017-04, Vol.25 (4), p.1127-1135

2017

Volltextzugriff (PDF)

Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial

The Lancet. Haematology, 2022-06, Vol.9 (6), p.e403-e414

2022

Volltextzugriff (PDF)

Treatment of Pancreatic and Periampullary Cancers at a Community Hospital: Successful Application of Tertiary Care Treatment Standards

International Journal of Surgical Oncology, 2011-01, Vol.2011 (2011), p.330-337

2011

Volltextzugriff (PDF)

Abstract CT128: Effects of adding budesonide or colestipol to loperamide prophylaxis on neratinib-associated diarrhea in patients (pts) with HER2+ early-stage breast cancer (eBC): the CONTROL trial

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.CT128-CT128

2017

Volltextzugriff (PDF)

An Expanded Treatment Protocol of Panobinostat Plus Bortezomib and Dexamethasone in Patients with Previously Treated Myeloma

Blood, 2015-12, Vol.126 (23), p.3027-3027

2015

Volltextzugriff (PDF)

Personality traits as a potential predictor of willingness to undergo various orthodontic treatments

The Angle orthodontist, 2013-09, Vol.83 (5), p.899-905

2013

Volltextzugriff (PDF)

M&a Disputes: A Professional Guide to Accounting Arbitrations

1st, 2017

Volltextzugriff (PDF)

Possible anaphylactic reaction to intravenous cyclophosphamide. Report of a case

JAMA : the journal of the American Medical Association, 1977-01, Vol.237 (5), p.475

1977

Volltextzugriff (PDF)

Cardiomyopathy after widely separated courses of adriamycin exacerbated by actinomycin‐D and mithramycin

Cancer, 1975-11, Vol.36 (5), p.1577-1584

1975

Volltextzugriff (PDF)

Microbial Protein Produced from Brown Seaweed and Spruce Wood as a Feed Ingredient

Journal of agricultural and food chemistry, 2018-08, Vol.66 (31), p.8328-8335

2018

Volltextzugriff (PDF)

Geomorphology of the Mirador-Calakmul Karst Basin: A GIS-based approach to hydrogeologic mapping

PloS one, 2021-08, Vol.16 (8), p.e0255496-e0255496

2021

Volltextzugriff (PDF)

TERNARY SOLUBILITY AND STUDY OF ASSOCIATION IN THE SYSTEM, METHOXYACETIC ACID, BENZENE AND WATER

HANSEN, PAUL VINCENT

1965

Volltextzugriff (PDF)

Age Group Comparability of Raw Accelerometer Output from Wrist- and Hip-Worn Monitors

Medicine and science in sports and exercise, 2014-09, Vol.46 (9), p.1816-1824

2014

Volltextzugriff (PDF)

Evaluation of raw acceleration sedentary thresholds in children and adults

Scandinavian journal of medicine & science in sports, 2017-12, Vol.27 (12), p.1814-1823

2017

Volltextzugriff (PDF)

LY2405319, an Engineered FGF21 Variant, Improves the Metabolic Status of Diabetic Monkeys

PloS one, 2013-06, Vol.8 (6), p.e65763

2013

Volltextzugriff (PDF)

1 – 25 von 749

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(613)
Mit Volltextzugriff
(661)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(448)
Life Sciences & Biomedicine
(326)
Humans
(242)
Male
(147)
Female
(140)
Physical Sciences
(94)
Middle Aged
(81)
Adult
(80)
Life Sciences
(62)
Aged
(58)
Biological And Medical Sciences
(56)
Physics
(53)
Medical Sciences
(47)
Animals
(43)
Patients
(38)
Science & Technology - Other Topics
(38)
Neurosciences & Neurology
(37)
Oncology
(37)
Multidisciplinary Sciences
(35)
Technology
(35)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(303)
MEDLINE
(289)
IngentaConnect
(286)
Ovid
(218)
NUS Single-Journal Subscriptions
(175)
Access via ScienceDirect (Elsevier)
(138)
IngentaConnect Journals
(133)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(80)
Wiley Online Library Journals
(79)
Ebook Central Perpetual and DDA
(75)
eBooks on EBSCOhost
(74)
Wiley Online Library
(56)
American Physical Society
(49)
Springer Journals
(48)
Oxford journals
(46)
Nature
(43)
JSTOR
(39)
Oxford Journals 2020 Medicine
(34)
PROLA - Physical Review Online Archive
(34)
Wiley Online Library All Obooks
(31)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Physical Review. C, Nuclear Physics
(16)
Plos One
(16)
Journal Of Hepatology
(15)
Physical Review Letters
(15)
Physical Review. D
(15)
Physical Review D
(14)
Heart Rhythm
(11)
Journal Of Clinical Oncology
(9)
Nature Genetics
(9)
Neurology
(8)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Randomized, Double-Blind, Placebo-Controlled Phase II Study of AMG 386 Combined With Weekly Paclitaxel in Patients With Recurrent Ovarian Cancer

An Expanded Treatment Protocol of Panobinostat Plus Bortezomib and Dexamethasone in Patients With Previously Treated Myeloma

Fixed combination of oral NEPA (netupitant‐palonosetron) for the prevention of acute and delayed chemotherapy‐induced nausea and vomiting in patients receiving multiple cycles of chemotherapy: Efficacy data from 2 randomized, double‐blind phase III studies

Phase 2 trial results with the novel neurokinin‐1 receptor antagonist casopitant in combination with ondansetron and dexamethasone for the prevention of chemotherapy‐induced nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma

Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

NEPA, a fixed oral combination of netupitant and palonosetron, improves control of chemotherapy-induced nausea and vomiting (CINV) over multiple cycles of chemotherapy: results of a randomized, double-blind, phase 3 trial versus oral palonosetron

Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial

Treatment of Pancreatic and Periampullary Cancers at a Community Hospital: Successful Application of Tertiary Care Treatment Standards

Abstract CT128: Effects of adding budesonide or colestipol to loperamide prophylaxis on neratinib-associated diarrhea in patients (pts) with HER2+ early-stage breast cancer (eBC): the CONTROL trial

An Expanded Treatment Protocol of Panobinostat Plus Bortezomib and Dexamethasone in Patients with Previously Treated Myeloma

Personality traits as a potential predictor of willingness to undergo various orthodontic treatments

M&a Disputes: A Professional Guide to Accounting Arbitrations

Possible anaphylactic reaction to intravenous cyclophosphamide. Report of a case

Cardiomyopathy after widely separated courses of adriamycin exacerbated by actinomycin‐D and mithramycin

Microbial Protein Produced from Brown Seaweed and Spruce Wood as a Feed Ingredient

Geomorphology of the Mirador-Calakmul Karst Basin: A GIS-based approach to hydrogeologic mapping

TERNARY SOLUBILITY AND STUDY OF ASSOCIATION IN THE SYSTEM, METHOXYACETIC ACID, BENZENE AND WATER

Age Group Comparability of Raw Accelerometer Output from Wrist- and Hip-Worn Monitors

GRANADA consensus on analytical approaches to assess associations with accelerometer-determined physical behaviours (physical activity, sedentary behaviour and sleep) in epidemiological studies

Evaluation of raw acceleration sedentary thresholds in children and adults

LY2405319, an Engineered FGF21 Variant, Improves the Metabolic Status of Diabetic Monkeys

Suchergebnisse filtern